eidos therapeutics logo

Eidos Therapeutics Inc.

Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”EID” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://eidostx.com
Founded2016
Disease Focus
Development StageClinical
STOCK CODENASDAQ: EID
Address
101 Montgomery St, STE 2550, CA 094101
San Francisco
United States
Email
Contact Number
+1 415 887 1471

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]